Zusammenfassung
Sekundäre Besiedelung des Katheters (keine klinische Relevanz).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Ausgewählte Literatur
Barth R (2010). Hohe Erfolgsrate bei schwer kranken Patienten mit Candidamie. Kongressbericht von der 44. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e.V. Tagung. Klinikarzt 10/2010.
Bartlett JG, Perl TM (2005) The new clostridium diffice – what does it mean? N Engl J Med 353: 2503–2505
Battegay M, Flückiger U (2003) Therapie schwerer Pilzinfektionen. Internist 44: 1549–1556
Beekmann SE (1999) Unfinished business: Assessing the efficacy of extraluminal silver ions on the prevention of microbial colonization and catheter-associated infection. Critical Care Medicine 27:456–458
Begg et al. (1999) Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. J Infect 39:1–15
Böhme A, Ruhnke M, Bushheidt D, Cornely OA et al. Treatmenz of invasive fungal infections in cancer patients – recommendations of the infectious diseases working party (AGIHO) of the German Society of Hematology and oncology (DGHO) (2008) Ann Hematol 88: 97–110
Cornely OA, Maertens J, Winston DJ et al (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348–359
Daum RS et al. (2001) Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall. Critical Care Medicine 29 (Suppl):92–96
De Gans J, van de Beek D (2002) The European Dexamethasone in adulthood bacterial meningitis study investigation. New Engl J Med 347:1549
Drew RH, Arthur RR, Perfect JR (2005) Is it time to abandon the use of Amphotericin B bladder irrigation? Clin Infect Dis 40: 1465–1470
Eckmanns T (2004) Hygienische Maßnahmen bei MRSA. J Anästhesie Intensivbehandlung 2:26
Eggimann P et al. (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072
Engel C et al. (2007) Intensive Care Med; 33: 606–18
Epidemiologieches Bulletin vom Robert-Kock-Institut (RKI) 2004; Nr. 46
Empfehlungen zur Prävention und Kontrolle von methicillinresistenten Staphylococcus aureus (MRSA)-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen (1999) Bundesgesundheitsblatt 42:954–958
Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2009 im Internet
Fridkin SK et al. (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. NEJM 352: 1436–44
Geffers C et al. (2004) Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anasthesiol Intensivmed Notfallmed Schmerzther 39: 15–19
Geldner G et al. (1999) Therapie und Prophylaxe bei MRSA-Infektion auf Intensivstationen. Intensivmedizin 36:612–618
Gonzalez P et al. (1999) Reduction of catheter-associated central line sepsis in a burn unit: A new methode of catheter care. Crit Care Med 27 (Suppl): 140A
Guery BP, Arendrup MC, Auzinger G et al (2009). Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med 35:206-214
Heizmann WR et al. (2004) Vademecum Infektiologie 2003/2004. Wyeth GmbH, Münster
Herbrecht et al. for the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group (2002) Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis. New Engl J Med 347:408-415
Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415
Klamareck K, Rosenthal E (2005) Therapie häufiger Infektionen in der täglichen Praxis. Eine Anleitung. Klinikarzt 34: 6
Kluge S (2009). Pilzinfektionen auf der Intensivstation. Lunch-Symposium. 41. Jahrestagung der Deutschen Gesellschaft fur internistische Intensivmedizin und Notfallmedizin. Hamburg 10.-13. Juni 2009
Koch S et al. (2005) Diagnostik und Therapie invasiver Pilzinfektionen auf der Intensivstation. Anaesthesist 54: 1047–1066
Leon C, Ruiz-Santana S, Saavedra P et al (2009) Usefulness of the »Candida score« for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633
Lichtenstein C et al (2010). Update: Invasive Pilzinfektion. Diagnose und Therapie in der operativen Intensivmedizin. Der Anasthesist 2010; 59:30–52.
Linder MW et al. (1987) Der Mannheimer Peritonitis-Index. Ein Instrument zur intraoperativen Prognose der Peritonitis. Chirurg 58:84–92
Lode M, Reiner CR. (2004) Therapie der Osteomyelitis Zeitschrift für Chemotherapie 25: 33–36
Loo VG et al. (2005) A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. New Engl J Med 353: 2442–2449
Maertens J, Theunissen K, Verhoef G et al (2005). Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infec tion: a prospective feasibility study. Clin Infect Dis 41:1242–1250
Maki DG, Weise CE, Sarafin HW (1977). A semiquantitave culture method of identifying intravenous-catheter-related infection. N Engl J Med 296: 1305–1309
Maschmeyer G, Ruhnke M (2002) Arzneimitteltherapie invasiver Candida- und Aspergillusinfektionen. Internist 43: 1464–1476
McDonald LC et al. (2005) An epidemic, toxin gene-variant strain of clostridium difficile.New Engl J Med 353: 2433–2441
McGee DC et al. (2003) Preventing complications of central venous catheterization. New Engl J Med 348:1123–1133
Meersseman W, Lagrou K, Maertens J et al (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177:27–34
Moller K et al. (2000) Guidelines for managing acute bacterial meningitis. BMJ 320:1290
Mora-Duarte J for the Caspofungin Invasive Candidiasis Study Group (2002) Comparison of caspofungin and amphotericin b for invasive candidiasis. New Engl J Med 347:2020–2029
Morrell M., Fraser V.J., Kollef M.H. (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother.;49 :3640–45.
Pappas PG et al (2009) Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the infectious diseases Society of America. Clinical Infect Dis 2009; 48: 503–535
Pappas PG, Rotstein CM, Betts RF et al (2007) Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 45:883–893
Parkins MD, Sabuda DM, Elsayed S, Laupland KB (2007) Adequacy of emperial antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60: 613–8
Pascual A, Calandra T, Bolay S et al (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 46:201–211
Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in criti cally ill surgical patients. Ann Surg 220:751–758
Quagliarello V et al. (1997) Treatment of bacterial meningitis. N Engl J Med 336:708–716
Quintel M et al. (2003) Infektionskrankheiten in der Intensivmedizin, 1. Aufl. Uni-Med-Verlag, Bremen
Reboli AC, Rotstein C, Pappas PG et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472–2482
Rimek D (2005) Wertigkeit des Aspergillus-Galaktomannan- Antigen-Nachweises zur Diagnostik invasiver Aspergillosen. Mikrobiologe 2: 72
Robert-Koch-Institut. www.rki.de. Empfehlungen der Kommission fur Krankenhaushygiene und Infektionspravention
Senn L, Robinson JO, Schmidt S et al (2008) 1,3-Beta-Dglucan antigenemia for early diagnosis of invasive fungal infections in neutropenic pati ents with acute leukemia. Clin Infect Dis 46:878–885
Trunkel AR, Scheid WM (2002) Editorial: Corticoid for everyone with meningitis? New Engl J Med 347:1613
Ullmann AJ, Lipton JH, Vesole DH et al (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:335–347
Wacha H et al. (2000) Antibiotikatherapie bei Peritonitis. J Anasthesie Intensivmed 1:223–226
Walsh TJ (2002) Echinocandins – An advance in the primary treatment of invasive candidiasis. New Engl J Med 347:2070–2072
Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360
Walsh TJ for the National Institute of Allergy and Infectious Diseases Mycoses Study Group (2002) Voriconazole compared with liposomal Amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. New Engl J Med 346:225–234
Wernitz Martin Henning (2006). Screening bei stationarer Aufnahme von Risikopatienten für die Kolonisation oder Infektion mit Methicillin-resistentem Staphylococcus aureus (MRSA). Eine Kohortenstudie über den Einfluss des Screenings auf die Häufigkeit nosokominaler MRSA-Infektionen mit einer Kostenanalyse vor dem Hintergrund des deutschen DRG-Fallpauschalen-Vergutungssystems. www.diss.fu-berlin.de/2006/607
Wernitz MH (2005). Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clinical Microbiol Infect, 11:457–465
Wernitz MH (2005). Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clinical Microbiol Infect, 11: 466–471
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fresenius, M., Heck, M. (2011). Spezielle Infektionen. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16879-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-16879-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16878-9
Online ISBN: 978-3-642-16879-6
eBook Packages: Medicine (German Language)